Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 94

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 94
---
15,127,621 | ​ | ​ | ​ | ​                       | ​ |   2,452,163 | ​ | ​ |
| Total stockholders’ deficit                        | ​ | ​ | ​                      | $ | -14,742,434 | ​ | ​ | ​ | ​                      | $ | -13,833,415 | ​ | ​ | ​ | ​                       | $ | -16,707,161 | ​ | ​ |

(1) As of September 30, 2024 and December 31, 2023, $32,580 of the $358,181 and $85,084 of the $156,425, respectively of the cash balances include restricted cash to be used for tax payments only.

24

TABLE OF CONTENTS

SUMMARY UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION The following summary unaudited pro forma combined financial information (the “Summary Pro Forma Information”) presents the combination of the financial information of Iris and Liminatus after giving effect to the transactions contemplated by the Business Combination Agreement, including the Business Combination, and related adjustments further described in the section entitled “ Unaudited Pro Forma Condensed Combined Financial Information. ”

| ​                                                                                                                       
 ​                                                                                                                       
 Summary Unaudited Pro Forma Condensed Combined Statement ofOperations Data For The Nine Months Ended September 30, 2024 | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Pro FormaCombined(Assuming NoAdditionalRedemptions) 
 (in thousands, except share and per share data)     
 ​                                                   | ​ |          ​ | ​ | ​ 
 ​ | ​ 
 ​ | Pro FormaCombined(AssumingMaximumRedemptions) 
 ​                                             | ​ |          ​ | ​ | ​ 
 ​ 
 ​ |
|:------------------------------------------------------------------------------------------------------------------------|:--|:--|:----------------------------------------------------|:--|-----------:|:--|:--|:--|:----------------------------------------------|:--|-----------:|:--|:--|
| Operating expenses                                                                                                      | ​ | ​ | ​                                                   | ​ |      5,547 | ​ | ​ | ​ | ​                                             | ​ |      5,547 | ​ | ​ |
| Loss from operations                                                                                                    | ​ | ​ | ​                                                   | ​ |     -5,547 | ​ | ​ | ​ | ​                                             | ​ |     -5,547 | ​ | ​ |
| Net loss                                                                                                                | ​ | ​ | ​